News

Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.…
Read More...

Ocugen, Inc., and Bharat Biotech announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN, an advanced stage…
Read More...

Engrail Therapeutics announced that it has acquired NeuroCycle Therapeutics, a company focused on sub-type selective GABA-A modulation. The acquisition strengthens Engrail’s presence in…
Read More...

Ampio Pharmaceuticals, Inc. a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data…
Read More...

Aeterna Zentaris Inc. through its wholly-owned subsidiary Aeterna Zentaris GmbH a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests…
Read More...

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, announced it has entered into an exclusive license agreement with Ono…
Read More...

Gilead Sciences, Inc. and Gritstone Oncology, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration with a…
Read More...

ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source novel targets and discover new therapeutics, announced a strategic…
Read More...

Eli Lilly and Company has partnered with local health systems to launch dedicated infusion center locations serving central, northern, and now southern Indiana that are intended to…
Read More...

Gan & Lee Pharmaceuticals Co., Ltd. a global biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for…
Read More...

Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological…
Read More...

Takeda Pharmaceutical Company Limited announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S.A. (“Hypera Pharma”)…
Read More...

Novartis announced that it has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting the production…
Read More...

Novavax, Inc. announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial…
Read More...

Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, announced it has commenced production of its inactivated,…
Read More...

Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma. AK1780 is an…
Read More...

Hoth Therapeutics, Inc. announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of…
Read More...

Sanofi and BioNTech have entered into an agreement under which Sanofi will support manufacturing and supply of BioNTech’s COVID-19 vaccine which is being co-developed with Pfizer.…
Read More...

Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company, announced a…
Read More...